• 6C Culture Medium Extends Mouse Corneal Epithelial Growth

  2026-08-27

  The reference study introduces a serum-free, multi-pathway 6C culture system that prolongs the proliferative activity of mouse corneal epithelial cells and improves epithelial-sheet production. Its practical significance lies in limiting epithelial–mesenchymal transdifferentiation while preserving progenitor-associated characteristics relevant to corneal repair and regenerative medicine.

• Tricine-SDS-PAGE Gel Preparation Kit Guide

  2026-08-27

  The Tricine-SDS-PAGE Electrophoresis System Gel Preparation Kit (SKU K4136) is intended for high-resolution protein electrophoresis and peptide separation when conventional Tris-SDS-PAGE does not adequately resolve low-molecular-weight targets. It is a research-use gel-casting system for denaturing or non-denaturing electrophoresis, not for diagnostic, clinical, or medical testing.

• Corydalis Alkaloids: PK Variability in MASH

  2026-08-26

  The reference study integrates pharmacokinetics, tissue distribution, transporter assays, and metabolic-enzyme analysis to show how MASH changes exposure to key Corydalis saxicola Bunting alkaloids. Its findings support disease-state-aware dosing and identify CYP450 enzymes, Oatp1b2, P-glycoprotein, and PXR as contributors to treatment-related variability.

• URB597: Reliable FAAH Assay Workflows

  2026-08-26

  Learn how URB597 (SKU A4372) can support controlled FAAH and endocannabinoid experiments while avoiding common interpretation, solvent, and timing errors in cell-based workflows. This scenario-driven guide connects product specifications with practical assay design and translational limitations.

• DAPT (GSI-IX): From Mechanism to Translation

  2026-08-25

  A mechanistic and strategic guide to using DAPT (GSI-IX) to interrogate γ-secretase, Notch signaling, APP processing, and organoid-based translational models.

• DiD for Membrane-Resolved Inflammation Assays

  2026-08-25

  DiD (DiDC 18 (5)) enables membrane-resolved imaging for migration, fusion, neuronal tracing, and immunofluorescence workflows. This article explains how to use the probe as a spatial assay variable when studying macrophage inflammation and diabetic periodontitis models.

• IGF2BP3–FZD1/7 Drives TNBC Stemness and Resistance

  2026-08-24

  The reference study identifies an IGF2BP3–FZD1/7 RNA-regulatory axis that links m6A recognition, β-catenin activation, cancer stem-like properties, and carboplatin resistance in triple-negative breast cancer. Its findings suggest that disrupting FZD1/7 signaling with Fz7-21 may sensitize TNBC stem-like cells to carboplatin, although clinical validation remains necessary.

• Human iPSC Hepatobiliary Organoids: Study Insights

  2026-08-24

  Wu et al. developed a staged, three-dimensional system that generates hepatobiliary organoids from human induced pluripotent stem cells without exogenous cells or genetic manipulation. The organoids reproduced several hepatocyte and cholangiocyte functions, providing a defined platform for studying liver development, disease mechanisms, and drug responses.

• Stattic: Reading STAT3 Signaling Across Cell Contexts

  2026-08-23

  Stattic is a STAT3 inhibitor that can function as more than a cancer-biology reagent: it is a causal probe for distinguishing pathway activation from downstream phenotype. This article connects HNSCC studies with new evidence from lymphatic endothelial cells and translates that comparison into practical assay decisions.

• Cholecystokinin Octapeptide Ammonium: Assay Guide

  2026-08-22

  Cholecystokinin octapeptide ammonium is a sulfated CCK-8 research reagent for dissecting receptor-dependent brain–gut signaling. This guide connects salt-form handling with pathway-aware assays spanning ANP secretion, neuronal apoptosis, immune responses, and behavior.

• Sulfo-NHS-SS-Biotin: Practical Labeling Guide

  2026-08-22

  Sulfo-NHS-SS-Biotin provides water-compatible labeling of accessible primary amines for reversible affinity capture and detection. It is suitable for protein and cell-surface workflows, but should not be used in amine-containing reaction buffers or when downstream reduction could disrupt native disulfide bonds.

• Precision cDNA for HFpEF Gene Expression

  2026-08-21

  Translational cardiovascular studies depend on more than a measurable phenotype: they require an RNA-to-data workflow that preserves biological signal. Using TGFBR1-driven remodeling in HFpEF as a case study, this article explains how primer choice, reverse transcriptase performance, and validation strategy can strengthen mechanistic conclusions while positioning the HyperScript™ First-Strand cDNA Synthesis Kit for demanding gene expression workflows.

• Intravesical p21 mRNA-LNP Therapy in Bladder Cancer

  2026-08-20

  This FASEB Journal study developed a nonviral lipid nanoparticle system for delivering chemically modified CDKN1A/p21 mRNA directly into the bladder. The approach restored nuclear p21, restrained tumor-associated cell-cycle activity, and reduced orthotopic bladder tumor growth while limiting systemic exposure in mice.

• Sorafenib Workflows for Tumor and Angiogenesis Models

  2026-08-20

  Use BAY-43-9006 as a mechanistic benchmark for Raf/MEK/ERK signaling, VEGFR-driven angiogenesis, and tumor proliferation inhibition. This workflow-oriented guide connects cell assays, endothelial tube formation, hepatocellular carcinoma models, and xenograft study design while addressing solubility and interpretation challenges.

• NET Formation in CML and Differential TKI Effects

  2026-08-19

  The reference study shows that neutrophil extracellular trap formation is already elevated in treatment-naïve chronic myeloid leukemia and is differentially modified by tyrosine kinase inhibitors. Its combination of patient-derived neutrophils with a BCR-ABL1-engineered differentiation model identifies PAD4-linked NET biology as a potential mechanistic bridge between CML and treatment-associated vascular risk.

7780 records 1/519 page Next 12345 下5页 Last page